The natural chemopreventive compound indole-3-carbinol: State of the science

In Vivo

Volumn 20, Issue 2, 2006, Pages 221-228

  Rogan, Eleanor G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

3,3' diindolylmethane (DIM); Anticancer effects; Apoptosis; Cell cycle arrest; Estrogen metabolism; Indole 3 carbinol (I3C); Review

Indexed keywords

3 INDOLEMETHANOL; ANTINEOPLASTIC AGENT; CARCINOGEN; CIDOFOVIR; ESTROGEN; TRABECTEDIN; TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOCHEMISTRY; BREAST CANCER; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CHEMOPROPHYLAXIS; DNA REPAIR; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG METABOLISM; DRUG POTENTIATION; DRUG STRUCTURE; ENDOMETRIUM CARCINOMA; ENZYME METABOLISM; HUMAN; HYDROLYSIS; HYDROXYLATION; LIVER TOXICITY; METASTASIS; NONHUMAN; PAPILLOMATOSIS; REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 33645761199     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Verhoeven DT, Goldbohm RA, van Poppel G, Verhagen H and van den Brandt PA: Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 5: 733-748, 1996.
2. Stoner G, Casto B, Ralston S, Roebuck B, Pereira C and Bailey G: Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol. Carcinogenesis 23: 265-272, 2002.
3. Xu M, Orner GA, Bailey GS, Stoner GD, Horio DT and Dashwood RH: Post-initiation effects of chlorophyllin and indole-3-carbinol in rats given 1,2-dimethylhydrazine or 2-amino-3-methyl- imidazo. Carcinogenesis 22: 309-314, 2001.
4. Rosen CA and Bryson PC: Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results. J Voice 18: 248-253, 2004.
5. de Bilderling G, Bodart E, Lawson G, Tuerlinckx D, Remacle M, Naesens L, De Clercq E and Snoeck R: Successful use of intralesional and intravenous Cidofovir in association with indole-3-carbinol in an 8-year-old girl with pulmonary papillomatosis. J Med Virol 75: 332-335, 2005
6. Hong C, Kim HA, Firestone GL and Bjeldanes LF: 3,3′-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 23: 1297-1305, 2002.
7. Chen I, McDougal A, Wang F and Safe S: Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19: 1631-1639, 1998.
8. Grose KR and Bjeldanes LF: Oligomerization of indole-3-carbinol in aqueous acid. Chem Res Toxicol 5: 188-193, 1992.
9. Anderton MJ, Manson MM, Verschoyle RD, Gescher A, Lamb JH, Farmer PB, Steward WP and Willinms ML: Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin Cancer Res 10: 5233-5241, 2004.
10. Arneson DW, Hurwitz A, McMahon LM and Robaugh D: Presence of 3.3′-diindolylmethane in human plasma after oral administration of indole-3-carbinol. Proc Am Assoc Cancer Res 40: 429, 1999.
11. Yoshida M, Katashima S, Ando J, Tanaka T, Uematsu F, Nakae D and Maekawa A: Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N′-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism. Carcinogenesis 25: 2257-2264, 2004.
12. Horn TL, Reichert MA, Bliss RL and Malejka-Giganti D: Modulations of P450 mRNA in liver and mammary gland and P450 activities and metabolism of estrogen in liver by treatment of rats with indole-3-carbinol. Biochem Pharmacol 64: 393-404, 2002.
13. Stresser DM, Bjeldanes LF, Bailey GS and Williams DE: The anticarcinogen 3,3′-diindolylmethane is an inhibitor of cytochrome P-450. J Biochem Toxicol 10: 191-201, 1995.
14. Carter TH, Liu K, Ralph W Jr, Chen D, Qi M, Fan S, Yuan F, Rosen EM and Auborn KJ: Diindolylmethane alters gene expression in human keratinocytes in vitro. J Nutr 132: 3314-3324, 2002.
15. Michnovicz JJ, Adlercreutz H and Bradlow HL: Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J Natl Cancer Inst 89: 718-723, 1997.
16. Reed GA, Peterson KS, Smith HJ, Gray JC, Sullivan DK, Mayo MS, Crowell JA and Hurwitz A: A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev 14: 1953-1960, 2005.
17. Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL and Bjeldanes LF: Pilot study: effect of 3,3′-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer 50: 161-167, 2004.
18. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T and Livingston DM: Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265-275, 1997.
19. Shen SX, Weaver Z, Xu X, Li C, Weinstein M, Chen L, Guan XY, Ried T and Deng CX: A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17: 3115-3124, 1998.
20. Harkin DP, Bean JM, Mildos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD and Haber DA: Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97: 575-586, 1999.
21. Yun J and Lee WH: Degradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damage. Mol Cell Biol 23: 7305-7314, 2003.
22. Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K and Fan S: Indole-3-carbinol is a negative regulator of estrogen receptor-α signaling in human tumor cells. J Nutr 130: 2927-2931, 2000.
23. Wang O, Zhang H, Kajino K and Greene MI: BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene 17: 1939-1948, 1998.
24. Fan S, Wang J, Yuan R, Ma Y, Meng Q, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID and Rosen EM: BRCA1 inhibition of estrogen receptor signaling in transfected cell Science 284: 1354-1356, 1999.
25. Meng Q, Qi M, Chen DZ, Yuan R, Goldberg ID, Rosen EM, Auborn K and Fan S: Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes. J Mol Med 78: 155-165, 2000.
26. Kim YS and Milner JA: Targets for indole-3-carbinol in cancer prevention. J Nutr Biochem 16: 65-73, 2005.
27. Rahman KM, Li Y and Sarkar FH: Inactivation of akt and NP-κB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr Cancer 48: 84-94, 2004.
28. Garcia HH, Brar GA, Nguyen DH, Bjeldanes LF and Fireston GL: Indole-3-carbinol (I3C) inhibits cyclin-dependent kinase-2 function in human breast cancer cells by regulating the size distribution, associated cyclun E forms, and subcellular localization of the CDK2 protein complex. J Biol Chem 280: 8756-8764, 2005.
29. 1 arrest of human mammary epithelial cells. Int J Cancer 118: 857-868, 2005.
30. 1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 20: 2927-2936, 2001.
31. Matsuzaki Y, Koyama M, Hitomi T, Kawanaka M and Sakai T: Indole-3-carbinol activates the cyclin-dependent kinase inhibitor p15(INK4b) gene. FEBS Lett 576: 137-140, 2004.
32. 1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 273: 3838-3847, 1998.
33. Cram EJ, Liu BD, Bjeldanes LF and Firestone GL: Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter. J Biol Chem 276: 22332-22340, 2001.
34. Rahman KW and Sarkar FH: Inhibition of nuclear translocation of nuclear factor-κB contributes to 3,3′-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Res 65: 364-371, 2005.
35. Chinni SR and Sarkar FH: Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res 8: 1228-1236, 2002.
36. Sarkar FH and Li Y: Indole-3-carbinol and prostate cancer. J Nutr 134: 3493S-3498S, 2004.
37. Nachshon-Kedmi M, Yannai S, Haj A and Fares PA: Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 41: 745-752, 2003.
38. Lee SH, Kim JS, Yamaguchi K, Eling TE and Baek SJ: Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent manner. Biochem Biophys Res Commun 328: 63-69, 2005.
39. Chen D, Carter TH and Auborn KJ: Apoptosis in cervical cancer cells: implications for adjunct anti-estrogen therapy for cervical cancer. Anticancer Res 24: 2649-2656, 2004.
40. Kuang YF and Chen YH: Induction of apoptosis in a non-small cell human lung cancer cell line by isothiocyanates is associated with p53 and p21. Food Chem Toxicol 42: 1711-1718, 2004.
41. Ge X, Fares FA and Yannai S: Induction of apoptosis in MCF-7 cells by indole-3-carbinol is independent of p53 and bax. Anticancer Res 19: 3199-3203, 1999.
42. Verhoeven DT, Verhagen H, Goldbohm RA, van den Brandt PA and van Poppel G: A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem Biol Interac 103: 79-129, 1997.
43. Bradlow HL, Michnovicz J, Telang NT and Osborne MP: Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12: 1571-1574, 1991.
44. Kojima T, Tanaka T and Mori H: Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 54: 1446-1449, 1994.
45. Garikapaty VP, Ashok BT, Chen YG, Mittelman A, Iatropoulos M and Tiwari RK: Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer. Oncol Rep 13: 89-93, 2005.
46. Shukla Y, Kalra N, Katiyar S, Siddiqui IA and Arora A: Chemopreventive effect of indole-3-carbinol on induction of preneoplastic altered hepatic foci. Nutr Cancer 50: 214-220, 2004.
47. Chang X, Tou JC, Hong C, Kim HA, Riby JE, Firestone GL and Bjeldanes LF: 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26: 771-778, 2005.
48. Donald S, Verschoyle RD, Greaves P, Colombo T, Zucchetti M, Falcioni C, Zaffaroni M, D'Incalci M, Manson MM, Jimeno J, Steward WP and Gescher AJ: Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma. Int J Cancer 111: 961-967, 2004.
49. Rosen CA, Woodson GE, Thompson JW, Hengesteg AP and Bradlow HL: Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 118: 810-815, 1998.
50. Snoeck R, Andrei G and De Clercq E: Cidofovir in the treatment of HPV-associated lesions. Verh K Acad Geneeskd Belg 63: 93-122, 2001.
51. Greenwald P: Clinical trials in cancer prevention: current results and perspectives for the future. J Nutr 134: 3507S-3512S, 2004.
52. Levine S: DIM, I3C, and the aryl hydrocarbon receptor. Focus, Allergy Research Group Newsletter 5-13, October 2005.
53. Castagnetta LA, Granata OM, Arcuri FP, Polito LM, Rosati F and Cartoni GP: Gas chromatography/mass spectrometry of catechol estrogens. Steroids 57: 437-443, 1992.
54. Liehr JG and Ricci MJ: 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93: 3294-3296, 1996.
55. Rogan EG, Badawi AF, Devanesan PD, Meza JL, Edney JA, West WW, Higginbotham SM and Cavalieri EL: Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 24: 697-702, 2003.